Targeting Protein Kinases for the Treatment of Glioblastoma Multiforme: Linking Basic Studies to Clinical...

Area of Science:

• Oncology
• Molecular Biology
• Neuro-oncology

Background:

• Glioblastoma multiforme (GBM) is a highly aggressive and heterogeneous primary brain tumor in adults.
• Protein kinases regulate critical cellular functions and are often dysregulated in cancer, driving tumor initiation and progression.
• Targeting protein kinases represents a significant therapeutic strategy for various cancers, including glioblastoma.

Purpose of the Study:

• To review the critical protein kinases and signaling pathways involved in glioblastoma.
• To elucidate the functional mechanisms of these kinases in glioblastoma tumorigenesis.
• To summarize recent preclinical and clinical advancements in targeting protein kinases for GBM treatment.

Main Methods:

• Literature review of scientific databases.
• Analysis of signaling pathways and kinase functions in glioblastoma.
• Synthesis of data on therapeutic agents targeting protein kinases.

Main Results:

• Identification of key protein kinases and aberrant signaling cascades in glioblastoma.
• Detailed explanation of kinase roles in glioblastoma development and progression.
• Overview of current and emerging therapeutic agents targeting these kinases.

Conclusions:

• Protein kinases are crucial therapeutic targets for glioblastoma.
• Targeted therapies show promise in preclinical and clinical settings for GBM.
• Further research into kinase inhibitors may lead to improved glioblastoma treatments.